IRIS PubliCatt

Nero, Camilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.016
EU - Europa 899
AS - Asia 378
AF - Africa 12
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.314
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.004
IT - Italia 250
SE - Svezia 201
DE - Germania 143
SG - Singapore 143
CN - Cina 121
IE - Irlanda 79
ID - Indonesia 52
UA - Ucraina 47
FR - Francia 37
GB - Regno Unito 36
FI - Finlandia 28
RU - Federazione Russa 26
IN - India 22
BE - Belgio 12
NL - Olanda 12
IR - Iran 8
KR - Corea 8
PH - Filippine 8
CA - Canada 7
TR - Turchia 7
AT - Austria 6
CI - Costa d'Avorio 6
ES - Italia 6
CZ - Repubblica Ceca 5
BR - Brasile 3
DO - Repubblica Dominicana 2
GF - Guiana Francese 2
HR - Croazia 2
JP - Giappone 2
MA - Marocco 2
MD - Moldavia 2
MX - Messico 2
MY - Malesia 2
NG - Nigeria 2
PE - Perù 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
EG - Egitto 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 2.314
Salva come PNG Salva come JPEG
Città #
Chandler 272
Ashburn 120
Singapore 115
Rome 77
Dublin 75
Ann Arbor 54
Jakarta 48
San Mateo 40
New York 39
Milan 37
Wilmington 29
Jacksonville 27
Boston 26
Moscow 22
Nanjing 22
Princeton 20
Cattolica 19
Marseille 18
Dearborn 17
Beijing 15
Helsinki 14
Boardman 13
Lawrence 11
Nürnberg 11
Brussels 10
Fairfield 10
Leawood 9
Los Angeles 9
Woodbridge 9
Munich 8
Redwood City 8
Washington 8
Bremen 7
Houston 7
Seattle 7
Abidjan 6
Bari 6
Vienna 6
Andover 5
Frankfurt am Main 5
Islington 5
Izmir 5
London 5
Mountain View 5
Naples 5
Turin 5
Augusta 4
Changsha 4
Genazzano 4
Hangzhou 4
Madrid 4
Toronto 4
Zhengzhou 4
Amsterdam 3
Detroit 3
Edinburgh 3
Hebei 3
Hefei 3
Jeju City 3
Lappeenranta 3
Martellago 3
Nanchang 3
Norwalk 3
Oliveri 3
Olomouc 3
Paris 3
Redmond 3
Sanford 3
Sanremo 3
Santa Clara 3
Shanghai 3
Ardabil 2
Asti 2
Bollate 2
Brno 2
Busto Arsizio 2
Cavite City 2
Cayenne 2
Chengdu 2
Chisinau 2
Civitavecchia 2
Clearwater 2
Coimbatore 2
Depok 2
Falkenstein 2
Gangnam-gu 2
Guangzhou 2
Jinan 2
Katsina 2
Kuala Lumpur 2
Kunming 2
Lanzhou 2
Leipzig 2
Lima 2
Manila 2
Mumbai 2
Osimo 2
Oujda 2
Pamplona 2
Parma 2
Totale 1.431
Salva come PNG Salva come JPEG
Nome #
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 129
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine 117
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 113
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 110
Targeting the hallmarks of ovarian cancer: The big picture 80
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 76
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 72
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications 72
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 69
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 68
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 68
The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method 68
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 64
Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 57
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: Prognostic role and clinical considerations 57
Oregovomab: an investigational agent for the treatment of advanced ovarian cancer 55
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 54
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 54
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 51
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer 47
Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study) 47
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 47
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center 45
Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma 45
Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY) 45
Laparotomy approach to sentinel lymph node detection in ovarian cancer using a near-infrared fluorescent system camera with indocyanine green dye 45
Minilaparoscopic Aortic Lymphadenectomy 44
Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY) 41
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 39
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 39
Newly diagnosed ovarian cancer: Which first-line treatment? 39
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 33
Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors 33
PARP Inhibitors Resistance: Mechanisms and Perspectives 31
Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique 30
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 28
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids 28
Recent progress in the use of pharmacotherapy for endometrial cancer 28
Mesenteric Lymph Node Involvement in Advanced Ovarian Cancer Patients Undergoing Rectosigmoid Resection: Prognostic Role and Clinical Considerations 28
Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy 24
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 22
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score–matched analysis 22
Advanced and recurrent endometrial cancer: State of the art and future perspectives 21
L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma 19
Management of stage III and IVa uterine cancer 19
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 18
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 18
Radiomics and Radiogenomics of Ovarian Cancer: Implications for Treatment Monitoring and Clinical Management 17
A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study 12
Totale 2.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.231
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020109 0 0 0 0 12 13 12 6 14 11 28 13
2020/2021143 15 12 6 10 18 8 9 5 14 10 29 7
2021/2022312 12 13 4 24 18 5 15 55 15 27 49 75
2022/2023737 93 96 52 115 37 91 34 53 74 16 32 44
2023/2024523 12 116 23 47 26 57 43 33 5 30 65 66
2024/2025299 39 28 96 60 76 0 0 0 0 0 0 0
Totale 2.388